European Leukemia Trial Registry
Trial: CML Glivec® in combination with Lonafarnib

More Details
Short Title CML Glivec® in combination with Lonafarnib
Trialgroup CML-Studiengruppe
Type of Trial multicentric
Disease Chronic myeloid leukemia(CML) Chronic Phase
Age All ages
Status Closed
Start of Recruitment 01.01.2005
Leader Hochhaus, Prof. Dr. med., Andreas
Contactperson

General Contact Person
Ehninger, Prof. Dr. med., Gerhard
Tel: +49 (0)351 458 4251
Fax: +49 (0)351 458 4367
Email: gerhard.ehninger@uniklinikum-dresden.de

General Contact Person
Einsele, Prof. Dr. med., Hermann
Tel: +49 (0)931 201-70000
Fax: +49 (0)931 201-70730
Email: einsele_h@klinik.uni-wuerzburg.de

General Contact Person
Hallek, Prof. Dr. med, Michael
Tel: +49 (0)221 478-4400
Fax: +49 (0)221 478-5455
Email: michael.hallek@uni-koeln.de
Homepage: www.medizin.uni-koeln.de/kliniken/innere1/mitarbeiter/index.shtml

General Contact Person
Scheid, Dr. med., Christof
Tel: +49 (0)221 478 4407
Email: c.scheid@uni-koeln.de

General Contact Person
Krause, PD Dr. med., Stefan
Tel: +49 (0)941 944 5538
Email: stefan.krause@klinik.uni-regensburg.de

Centre of Trial Medizinische Fakultät Mannheim der Universität Heidelberg
Shortprotocol Shortprotocol
created 29.06.2006 Anja Hellenbrecht
changed 13.11.2014 Alexandra Lucaciu
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org